Pfizer (PFE.US) and BioNTech (BNTX.US) released upbeat news regarding vaccine
Major indices rose sharply on Wednesday after Pfizer (PFE.US) and BioNTech (BNTX.US) confirmed that three vaccine doses neutralize Omicron variant, while two-dose vaccine may still prevent severe disease. Also both companies said, that Omicron variant-specific vaccine could be available by March
Right after the publication of this information, we can observe a positive reaction from risky assets. In the meantime, there have also been reports of new restrictions in the UK, but it seems that at the moment they are being ignored by the market.
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appGerman DAX (DE30), similarly to other European indices and US contracts moved higher and the price is getting closer to yesterday's highs. On the other hand, if reports regarding vaccine efficacy provoked only a temporary response, the key support is located around 15,663 points, which is marked with the lower limit of the 1: 1 structure and 23.6% Fibonacci retracement of the last upward wave.
DE30, M15 interval. Source:xStation5
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.